The potential economic value of influenza vaccination for healthcare workers in The Netherlands

Marjan J Meijboom, Josien Riphagen-Dalhuisen, Eelko Hak, Marjan J Meijboom, Josien Riphagen-Dalhuisen, Eelko Hak

Abstract

Background: Despite the clinical evidence, influenza vaccination coverage of healthcare workers remains low. To assess the health economic value of implementing an influenza immunization program among healthcare workers (HCW) in University Medical Centers (UMCs) in the Netherlands, a cost-benefit model was developed using a societal perspective.

Methods/patients: The model was based on a trial performed among all UMCs in the Netherlands that included both hospital staff and patients admitted to the pediatrics and internal medicine departments. The model structure and parameters estimates were based on the trial and complemented with literature research, and the impact of uncertainty explored with sensitivity analyses.

Results: In a base-case scenario without vaccine coverage, influenza-related annual costs were estimated at € 410 815 for an average UMC with 8000 HCWs and an average occupancy during the influenza period of 6000 hospitalized patients. Of these costs, 82% attributed to the HCWs and 18% were patient-related. With a vaccination coverage of 15.47%, the societal program's savings were € 2861 which corresponds to a saving of € 270.53 per extended hospitalization. Univariate sensitivity analyses show that the results are most sensitive to changes in the model parameters vaccine effectiveness in reducing influenza-like illness (ILI) and the vaccination-related costs.

Conclusion: In addition to the decreased burden of patient morbidity among hospitalized patients, the effects of the hospital immunization program slightly outweigh the economic investments. These outcomes may support healthcare policymakers' recommendations about the influenza vaccination program for healthcare workers.

Trial registration: ClinicalTrials.gov NCT01481467.

Keywords: economic value; healthcare workers; hospital; implementation; influenza; patients; vaccination.

© 2018 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.

Figures

Figure 1
Figure 1
Tornado diagram
Figure 2
Figure 2
Costs related to vaccination coverage of HCW’s

References

    1. Wilde JA, McMillan JA, Serwint J, Butta J, O’Riordan MA, Steinhoff MC. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA. 1999;281:908‐913.
    1. Hayward AC, Harling R, Wetten S, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ. 2006;333:1241.
    1. Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of health care workers in long‐term‐care hospitals reduces the mortality of elderly patients. J Infect Dis. 1997;175:1‐6.
    1. Lemaitre M, Meret T, Rothan‐Tondeur M, et al. Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster‐randomized trial. J Am Geriatr Soc. 2009;57:1580‐1586.
    1. Thomas RE, Jefferson T, Lasserson TJ. Influenza vaccination for healthcare workers who work with the elderly: systematic review. Vaccine. 2010;29:344‐356.
    1. Jefferson T, Di Pietrantonj C, Rivetti A, Bawazeer GA, Al‐Ansary LA, Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2010;(7):CD001269.
    1. Riphagen‐Dalhuisen J, Burgerhof JG, Frijstein G, et al. Hospital‐based cluster randomised controlled trial to assess effects of a multi‐faceted programme on influenza vaccine coverage among hospital healthcare workers and nosocomial influenza in the Netherlands, 2009 to 2011. Euro Surveill. 2013;18:20512.
    1. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health‐care workers on mortality of elderly people in long‐term care: a randomised controlled trial. Lancet. 2000;355:93‐97.
    1. Thomas RE, Jefferson T, Lasserson TJ. Influenza vaccination for healthcare workers who care for people aged 60 or older living in long‐termcare institutions Cochrane Database Syst Rev. 2016;(6):CD005187.
    1. Salgado CD, Giannetta ET, Hayden FG, Farr BM. Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol. 2004;25:923‐928.
    1. Strategic Advisory Group of Experts on Immunization . Report of the extraordinary meeting on the influenza A (H1N1) 2009 pandemic, 7 July 2009. Wkly Epidemiol Rec. 2009;84:301‐304.
    1. Music T. Protecting patients, protecting healthcare workers: a review of the role of influenza vaccination. Int Nurs Rev. 2012;59:161‐167.
    1. Maltezou HC, Wicker S, Borg M, et al. Vaccination policies for health‐care workers in acute health‐care facilities in Europe. Vaccine. 2011;29:9557‐9562.
    1. Committee on infectious diseases . Influenza Immunization for All Health Care Personnel: keep It Mandatory. Pediatrics. 2015;136:809‐818.
    1. CDC . Influenza Vaccination Information for Health Care Workers [Internet]. 2017. Available from: Accessed cited July 15, 2017.
    1. Black CL, Yue X, Ball SW, et al. Influenza Vaccination Coverage Among Health Care Personnel ‐ United States, 2014‐15 Influenza Season. MMWR Morb Mortal Wkly Rep. 2015;64:993‐999.
    1. Nichol KL, D’Heilly SJ, Greenberg ME, Ehlinger E. Burden of influenza‐like illness and effectiveness of influenza vaccination among working adults aged 50‐64 years. Clin Infect Dis. 2009;48:292‐298.
    1. Blank PR, Schwenkglenks M, Szucs TD. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J Infect. 2009;58:446‐458.
    1. Kroneman M, Paget WJ, van Essen GA. Influenza vaccination in Europe: an inventory of strategies to reach target populations and optimise vaccination uptake. Euro Surveill Bull Eur sur les Mal Transm = Eur Commun Dis Bull. 2003;8:130‐138.
    1. Mereckiene J, Cotter S, D’Ancona F, et al. Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008‐2009. Euro Surveill. 2010;15:pii:19700.
    1. Sloot R, Hooiveld M, ten Veen PMH, Korevaar J. Factsheet Vaccine Coverage Dutch National Influenza Prevention Program2014 [Internet]. Utrecht: NIVEL; 2015. Available from: Accessed May 9, 2017.
    1. Sloot R, Hooiveld M, ten Veen P, Korevaar J. Vaccinatiegraad Nationaal Programma Grieppreventie 2014[Internet]. Utrecht: Nivel; 2015. Available from: Accessed May 9, 2017.
    1. Riphagen‐Dalhuisen J, Frijstein G, van der Geest‐Blankert N, et al. Planning and process evaluation of a multi‐faceted influenza vaccination implementation strategy for health care workers in acute health care settings. BMC Infect Dis. 2013;13:235.
    1. Hak E, Knol LM, Wilschut JC, Postma MJ. Influenza vaccination of hospital healthcare staff from the perspective of the employer: a positive balance [Dutch: Influenzavaccinatie van ziekenhuismedewerkers vanuit werkgeversperspectief]. Ned Tijdschr Geneeskd. 2010;154:1757‐1763.
    1. ErasmusMC . Nieuwsbrief Influenza Surveillance [Internet]. Vol. 2015. 2015. Available from: Accessed December 12, 2016.
    1. van den Dool C, Bonten MJM, Hak E, Wallinga J. Modeling the effects of influenza vaccination of health care workers in hospital departments. Vaccine. 2009;27:6261‐6267.
    1. Hakkaart‐van Roijen L, Van der Linden N, Bouwmans C, Kanters T, Tan SS. Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg. Diemen; 2015.
    1. Netherlands S. Consumer prices index [Internet]. Vol. 2015. 2015. Available from: Accessed May 15, 2017.
    1. Postma MJ, Jansema P, Scheijbeler HWKFH, Van Genugten MLL. Scenarios on costs and savings of influenza treatment and prevention for Dutch healthy working adults. Vaccine. 2005;23:5365‐5371.
    1. Friesema IHM, Koppeschaar CE, Donker GA, et al. Internet‐based monitoring of influenza‐like illness in the general population: experience of five influenza seasons in The Netherlands. Vaccine. 2009;27:6353‐6357.
    1. Medicijnkosten [Medicine costs] [Internet]. 2017. Available from: Accessed July 3, 2017.
    1. Palmer LA, Rousculp MD, Johnston SS, Mahadevia PJ, Nichol KL. Effect of influenza‐like illness and other wintertime respiratory illnesses on worker productivity: the child and household influenza‐illness and employee function (CHIEF) study. Vaccine. 2010;28:5049‐5056.
    1. Saxen H, Virtanen M. Randomized, placebo‐controlled double blind study on the efficacy of influenza immunization on absenteeism of health care workers. Pediatr Infect Dis J. 1999;18:779‐783.
    1. Keech M, Beardsworth P. The impact of influenza on working days lost: a review of the literature. Pharmacoeconomics. 2008;26:911‐924.
    1. Elder AG, O’Donnell B, McCruden EA, Symington IS, Carman WF. Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993‐4 epidemic: results of serum testing and questionnaire. BMJ. 1996;313:1241‐1242.
    1. Rozenbaum MH, Sanders EAM, van Hoek AJ, et al. Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines. BMJ. 2010;340:c2509.
    1. European Centre for Disease Prevention and Control . Seasonal influenza vaccination in Europe. Vaccination recommendations and coverage rates in the EU Member States for eight influenza seasons: 2007‐2008 to 2014‐2015. Stockholm, Sweden: ECDC; 2017.
    1. van Gageldonk‐Lafeber AB, Dijkstra F, van‘t Veen H, Orchudesch M, van der Hoek W. Low influenza vaccination coverage rate among hospital employees. Ned Tijdschr Geneeskd. 2014;158:A7650.
    1. Black CL, Yue X, Ball SW, et al. Influenza vaccination coverage among health care personnel — United States, 2015–16 influenza season. MMWR Morb Mortal Wkly Rep 2016;65:1026‐1031.
    1. Darvishian M, Dijkstra F, vanDoorn E , et al. Influenza vaccine effectiveness in the Netherlands from 2003/2004 through 2013/2014: the importance of circulating influenza virus types and subtypes. PLoS One. 2017;12(1):e0169528.
    1. Liu H, Frijlink HW, Huckriede A, et al. Influenza Vaccine Research funded by the European Commission FP7‐Health‐2013‐Innovation‐1 project. Vaccine [Internet]. 2016;34:5845‐5854.
    1. Taylor G, Mitchell R, McGeer A, et al. Healthcare‐associated influenza in Canadian hospitals from 2006 to 2012. Infect Control Hosp Epidemiol. 2014;35:169‐175.
    1. Cunney RJ, Bialachowski A, Thornley D, Smaill FM, Pennie RA. An outbreak of influenza A in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2000;21:449‐454.
    1. Weinstock DM, Eagan J, Malak SA, et al. Control of influenza A on a bone marrow transplant unit. Infect Control Hosp Epidemiol. 2000;21:730‐732.
    1. Salgado CD, Farr BM, Hall KK, Hayden FG. Influenza in the acute hospital setting. LancetInfectious Dis. 2002;2:145‐155.
    1. Sartor C, Zandotti C, Romain F, et al. Disruption of services in an internal medicine unit due to a nosocomial influenza outbreak. Infect Control Hosp Epidemiol. 2002;23:615‐619.
    1. Ahmed F, Lindley MC, Allred N, Weinbaum CM, Grohskopf L. Effect of influenza vaccination of healthcare personnel on morbidity and mortality among patients: systematic review and grading of evidence. Clin Infect Dis. 2014;58:50‐57.
    1. Griffin MR. Influenza vaccination of healthcare workers: making the grade for action. Clin Infect Dis. 2014;58:58‐60.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する